封面
市場調查報告書
商品編碼
1918139

乳房植入市場-2026-2031年預測

Breast Implants Market - Forecast from 2026 to 2031

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2025 年,乳房植入市場規模將達到 29.12 億美元,到 2031 年將達到 45.01 億美元,複合年成長率為 7.53%。

乳房植入市場正以7.53%的強勁複合年成長率成長,預計到2031年將達到45.01億美元。這些醫療設備透過外科手術改善乳房的大小和形狀,兼具美容和重組的雙重功能。乳癌發生率的上升、人們對美學的日益關注、對乳房重建的認知不斷提高、植入系統技術的進步以及可支配收入的增加,都是推動市場擴張的因素。

主要市場促進因素

乳癌盛行率和重組手術

乳房植入常用於乳癌切除術術後的乳房重建手術。乳癌病例的不斷增加預計將顯著推動市場成長。乳癌是全球最常見的癌症類型。 2020年,全球約有230萬例新增乳癌病例,導致約68.5萬人死亡。國際癌症研究機構(IARC)估計,到2040年,每年新增乳癌病例將超過300萬例(增加40%),每年死亡人數將超過100萬人(增加50%)。日益加重的疾病負擔導致乳房植入重組手術的持續需求。

美容意識和美容需求

近年來,越來越多的人選擇透過整形手術來改善自身外觀。社會對美和身材的日益關注推動了隆乳植入市場的發展。根據國際美容整形外科學會(ISAPS)發布的《2023年全球美容整形手術調查報告》,2021年全球整形外科醫師實施的手術總數顯著增加了19.3%。調查顯示,2021年全球共進行了超過1,280萬例手術和約1,750萬例非手術治療。隆乳手術是女性最常見的整形手術,顯示已被廣泛接受和接受。

技術創新

乳房植入材料和設計的創新提高了安全性、耐用性和自然外觀。表面處理技術的進步,例如紋理植入,有助於降低植入旋轉和包膜攣縮的風險。現代乳房植入通常採用高凝聚性矽膠,即使植入外殼受損,也能保持其形狀和完整性。奈米技術也透過創建奈米結構表面來影響乳房植入的研發,這些表面可以促進組織整合並減少包膜攣縮等併發症。先進的3D影像和模擬技術使患者能夠在術前預覽潛在的手術效果,從而幫助患者做出更明智的決定並提高患者滿意度。

經濟可及性

各地經濟繁榮和可支配收入的成長使得整形手術更加經濟實惠,也讓隆乳植入在更廣泛的人群中流行起來。可支配收入的成長預計將推動市場成長。 2019-20會計年度,印度可支配所得總額成長6.4%,達204.22兆印度盧比。 2021年,中國人均可支配所得為35,128元人民幣(約5,523美元),以名目價值計算年增9.1%。這些經濟改善正在擴大整形和重組乳房手術的潛在市場。

市場約束

儘管乳房植入市場呈現成長趨勢,但仍面臨許多挑戰。植入本身的費用、外科醫生費用、麻醉費用以及術後護理費用加起來可能是一筆不小的開支。對部分企業而言,經濟負擔構成了市場擴張的障礙,並可能對市場成長產生負面影響。植入破裂、包膜攣縮、植入相關異生性大細胞淋巴瘤(BIA-ALCL)以及潛在的長期健康影響等問題,引發了人們對乳房植入安全性的擔憂。這些擔憂導致衛生部門和監管機構加強了審查,可能影響消費者信心和市場需求。製造商必須透過改進設計和提高資訊透明度來持續解決這些安全問題。

區域趨勢

預計在預測期內,北美市場將佔據顯著的市場佔有率,這主要得益於乳癌病例的增加、可支配收入的成長、健全的醫療保健體係以及對技術創新的早期應用。乳癌是美國第二大常見癌症,約佔每年女性新確診癌症病例的30%。隆乳手術名列美國五大外科手術之列,顯示其在北美美容醫學領域佔有舉足輕重的地位。

市場參與企業和近期趨勢

主要市場參與企業包括 Polytech Health & Aesthetics GmbH,該公司提供 Polytech Patient Pathway™ 和輕型 B-Lite®植入;Motiva Implants,該公司以其符合人體工學的凝膠填充乳房植入Ergonomix 系列而聞名,該系列植入物旨在適應患者的運動;以及 Groupe 植入 SAS,完整性公司提供在內的乳房植入方案

乳房植入市場持續發展,其驅動力包括技術日益成熟、手術接受度不斷提高,以及乳癌術後重組和選擇性美容手術的雙重需求。安全性不斷提升、美學效果更加顯著、經濟可及性增強,預計這些因素將推動市場持續成長,製造商也將不斷創新以應對臨床挑戰並滿足不同患者的偏好。

本報告的主要優勢:

  • 深入分析:取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察,涵蓋主要地區和新興地區。
  • 競爭格局:了解主要企業採取的策略舉措,並了解透過正確的策略實現市場滲透的潛力。
  • 市場促進因素與未來趨勢:探索動態因素和關鍵市場趨勢,以及它們將如何塑造未來的市場發展。
  • 可執行的建議:利用洞察力為策略決策提供訊息,從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣:對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的?

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

  • 歷史資料(2021-2025 年)和預測資料(2026-2031 年)
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區(國家)分類的收入成長和預測分析
  • 公司概況(策略、產品、財務資訊、關鍵趨勢等)

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 依產品分類的乳房植入市場

  • 介紹
  • 矽膠植入
  • 生理食鹽水植入

第6章 依形狀分類的乳房植入市場

  • 介紹
  • 圓形的
  • 解剖學

第7章 依應用分類的乳房植入市場

  • 介紹
  • 重組手術
  • 整形手術

第8章 各地區乳房植入市場

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第10章:公司簡介

  • ALLERGAN(ABBVIE INC.)
  • GC Aesthetics
  • GROUPE SEBBIN SAS
  • J&J MedTech
  • Sientra Inc.
  • Polytech Health & Aesthetics GmbH
  • Motiva Implants
  • Guangzhou Wanhe Plastic Materials Co., Ltd.
  • LABORATOIRES ARION

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061615921

The breast implants market, with a 7.53% CAGR, is projected to rise from USD 2.912 billion in 2025 to USD 4.501 billion in 2031.

The breast implants market is experiencing robust growth at a 7.53% CAGR, projected to reach USD 4.501 billion in 2031. These medical devices-used to enhance breast size and shape through surgical procedures-serve both cosmetic and reconstructive purposes. Rising breast cancer prevalence, increasing beauty consciousness, awareness about breast reconstruction, technological advancements in implant systems, and rising disposable income are propelling market expansion.

Primary Market Drivers

Breast Cancer Prevalence and Reconstruction

Breast implants are commonly used in breast reconstruction procedures following mastectomy due to breast cancer. Rising breast cancer cases are expected to propel market growth substantially. Breast cancer represents the most prevalent cancer type globally. Approximately 2.3 million new breast cancer instances occurred in 2020, with approximately 685,000 deaths worldwide. The IARC estimates that by 2040, there will be more than 3 million new breast cancer instances annually-a 40% increase-and more than 1 million annual fatalities-a 50% increase. This growing disease burden creates sustained demand for reconstructive procedures utilizing breast implants.

Beauty Consciousness and Cosmetic Demand

Recent years have witnessed growing trends of people seeking cosmetic enhancements to improve physical appearance. Increasing emphasis on beauty and body image in society has driven the breast implants market. According to the 2023 annual Global Survey on Aesthetic/Cosmetic Procedures conducted by the International Society of Aesthetic Plastic Surgery, plastic surgeons worldwide reported a significant 19.3% increase in overall procedures performed in 2021. The survey revealed that more than 12.8 million surgical procedures and approximately 17.5 million non-surgical procedures were conducted globally during that year. Breast augmentation was the most common surgical procedure for women, demonstrating the procedure's mainstream acceptance and popularity.

Technological Innovation

Technological innovations in breast implant materials and design have improved safety, durability, and natural appearance. Advancements in implant surfaces, such as textured implants, have helped reduce the risk of implant rotation and capsular contracture. Modern breast implants often use cohesive silicone gel, which maintains shape and integrity even if the implant shell is compromised. Nanotechnology has influenced breast implant development by creating nanostructured surfaces that enhance tissue integration and reduce complications like capsular contracture. Advanced 3D imaging and simulation technologies allow patients to visualize potential outcomes before undergoing surgery, supporting improved decision-making and patient satisfaction.

Economic Accessibility

Economic prosperity and increasing disposable income in various regions have allowed more individuals to afford cosmetic procedures, making breast implants more accessible to broader demographics. Rising disposable income is expected to bolster market growth. India's gross disposable income witnessed 6.4% growth in fiscal year 2019-20, reaching Rs. 204.22 lakh crore. China's per capita disposable income was 35,128 yuan (approximately $5,523) in 2021, an increase of 9.1% year over year in nominal terms. These economic improvements expand the addressable market for both cosmetic and reconstructive breast procedures.

Market Constraints

Despite positive growth trajectories, the breast implants market faces challenges. The cost of implants, surgeon's fees, anesthesia, and post-operative care may accumulate to significant expenses. Affordability might be a limiting factor for some people, potentially negatively impacting market expansion. Issues such as implant rupture, capsular contracture, implant-associated anaplastic large cell lymphoma (BIA-ALCL), and potential long-term health effects have raised questions about breast implant safety profiles. These concerns have led to increased scrutiny by health authorities and regulatory bodies, potentially affecting consumer confidence and market demand. Manufacturers must continuously address these safety concerns through improved designs and transparent communication.

Regional Dynamics

North America is expected to hold significant market share during the forecast period, supported by rising breast cancer cases, increasing disposable income, strong healthcare systems, and earlier adoption of technological advancements. Breast cancer is the second highest diagnosed cancer in the U.S., contributing to around 30% of all new female cancers each year. Breast augmentation ranks among the top 5 surgical procedures in America, demonstrating the procedure's established position in the region's aesthetic medicine landscape.

Market Players and Recent Developments

Major market players include Polytech Health & Aesthetics GmbH, offering Polytech Patient Pathway(TM) and B-Lite(R) lightweight implants; Motiva Implants, known for Ergonomix range of ergonomic gel-filled breast implants designed to adapt to patient movements; and Groupe Sebbin SAS, providing breast implant solutions including Sensity, Volupty, Purity, and Integrity.

The breast implants market continues evolving, driven by technological sophistication, growing procedural acceptance, and the dual demand from reconstructive needs following breast cancer treatment and elective cosmetic enhancement procedures. The convergence of improved safety profiles, enhanced aesthetic outcomes, and expanding economic accessibility positions the market for sustained growth as manufacturers innovate to address clinical challenges while meeting diverse patient preferences.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Breast Implants Market Segmentation

  • By Product
  • Silicone Breast Implants
  • Saline Breast Implants
  • By Shape
  • Round
  • Anatomical
  • By Application
  • Reconstructive Surgery
  • Cosmetic Surgery
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BREAST IMPLANTS MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Silicone Breast Implants
  • 5.3. Saline Breast Implants

6. BREAST IMPLANTS MARKET BY SHAPE

  • 6.1. Introduction
  • 6.2. Round
  • 6.3. Anatomical

7. BREAST IMPLANTS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Reconstructive Surgery
  • 7.3. Cosmetic Surgery

8. BREAST IMPLANTS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. ALLERGAN (ABBVIE INC.)
  • 10.2. GC Aesthetics
  • 10.3. GROUPE SEBBIN SAS
  • 10.4. J&J MedTech
  • 10.5. Sientra Inc.
  • 10.6. Polytech Health & Aesthetics GmbH
  • 10.7. Motiva Implants
  • 10.8. Guangzhou Wanhe Plastic Materials Co., Ltd.
  • 10.9. LABORATOIRES ARION

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations